PharmOptima LLC Scientist Presents Study Poster at ARVO 2013

Wednesday, May 15, 2013

PORTAGE, MICHIGAN, Wednesday, May 15, 2013– PharmOptima LLC announced that five of its scientists authored a study paper presented by Mr. Douglas Decker at ARVO 2013 held in Seattle last week. The abstract entitled “VEGF, VEGF-C, and VEGF-D Increases in Aqueous Humor Samples in a LPS Induced Model of Uveitis in New Zealand White Rabbits” was co-authored by Mr. Douglas Decker, Mr Jeff Burr, Kelly Lester, Ms. Vicki Zaworski and Dr Stephen Weber, all from PharmOptima LLC in Portage, Michigan.

Mr. Douglas Decker, Vice President, Director of Biochemistry & Cell Biology at PharmOptima, said “...VEGF, VEGF-C, and VEGF-D levels increased significantly in LPS treated eyes of NZW and are indicative of an inflammatory response. Ophthalmic exams, cell counts, and protein increases in LPS treated eyes support increased inflammation in this rabbit model of uveitis. The significantly increased levels of VEGF-C and VEGF-D in AH are new findings.”

The poster can be viewed in detail at the PharmOptima website www.pharmoptima.com.

Contact Information:

PharmOptima LLC

Mr. Douglas Decker, Vice President, Director of Biochemistry & Cell Biology

Tel. 269-329-4370